Table of Content

1 Market Introduction
1.1 Market Definition
1.2 Research Scope and Segmentation
1.3 Stakeholders
1.4 List of Abbreviations


2 Executive Summary


3 Research Methodology


4 Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Market Challenges
4.5 Impact of COVID-19 on Vaccines Market


5 Porter’s Five Force Analysis
5.1 Bargaining Power of Suppliers
5.2 Bargaining Power of Buyers
5.3 Threat of New Entrants
5.4 Threat of Substitutes
5.5 Competitive Rivalry in the Market


6 Global Vaccines Market by, Type
6.1 Overview
6.2 Recombinant/Conjugate/Subunit
6.3 Inactivated
6.4 Live Attenuated
6.5 Toxoid


7 Global Vaccines Market by, Route of Administration
7.1 Overview
7.2 Parenteral
7.3 Oral


8 Global Vaccines Market by, Disease Indication
8.1 Overview
8.2 Viral Diseases
8.2.1 Hepatitis
8.2.2 Influenza
8.2.3 Human Papillomavirus
8.2.4 Measles/Mumps/Rubella
8.2.5 Rotavirus
8.2.6 Herpes Zoster
8.2.7 Other Viral Diseases
8.3 Bacterial Diseases
8.3.1 Meningococcal Disease
8.3.2 Pneumococcal Disease
8.3.3 Diphtheria/Tetanus/Pertussis
8.3.4 Other Bacterial Diseases


9 Global Vaccines Market by, Age Group
9.1 Overview
9.2 Pediatric
9.3 Adults


10 Global Vaccines Market by, Distribution Channel
10.1 Overview
10.2 Hospital & Retail Pharmacies
10.3 Government Suppliers
10.4 Other Distribution Channels


11 Global Vaccines Market by, Geography
11.1 Overview
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 UK
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Australia
11.4.6 New Zealand
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Brazil
11.5.2 Argentina
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 UAE
11.6.2 Saudi Arabia
11.6.3 Qatar
11.6.4 Iran
11.6.5 South Africa
11.6.6 Rest of Middle East & Africa


12 Key Developments


13 Company Profiling
13.1 GlaxoSmithKline plc.
13.1.1 Business Overview
13.1.2 Product/Service Offering
13.1.3 Financial Overview
13.1.4 SWOT Analysis
13.1.5 Key Activities
13.2 Mitsubishi Tanabe Pharma Corporation
13.3 Inovio Pharmaceuticals, Inc.
13.4 Novartis AG
13.5 Emergent BioSolutions, Inc.
13.6 BHARAT BIOTECH
13.7 SANOFI
13.8 Bavarian Nordic
13.9 Pfizer Inc.
13.10 Merck & Co., Inc.
13.11 CSL Limited
13.12 NOVAVAX
13.13 SERUM INSTITUTE OF INDIA PVT., LTD.
13.14 Panacea Biotec
13.15 DAIICHI SANKYO COMPANY, LIMITED